[Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria].
D004341:Drug Evaluation; D004351:Drug Resistance; D006801:Humans; D008288:Malaria / Q000188:drug therapy / Q000517:prevention & control*; D010880:Piperidines / Q000627:therapeutic use; D010963:Plasmodium falciparum / Q000187:drug effects*; D011739:Pyrimethamine / Q000627:therapeutic use; D011803:Quinine / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D013424:Sulfanilamides / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use
D010880:Piperidines; D011804:Quinolines; D013424:Sulfanilamides; D013450:Sulfones; D011803:Quinine; D011739:Pyrimethamine
Lekarstvennaia ustoĭchivost' maliariĭnykh parazitov. Soobshcheniie II. Klinicheskiĭ aspekt, lechenie i khimioprofilaktika lakarstvennoustoĭchivoĭ maliarii